be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

Most popular

searches

All articles

Filters:

Show search box

2013-12-02

Synektik SA enters a market worth $2,000,000,000

Synektik SA enters a market worth $2,000,000,000

Synektik SA – a leader in providing innovative products, services and IT solutions for diagnostic imaging and nuclear medicine signed the $4,000,000 contract for licenses and joint research and development with the Israel company Hadasit Medical Resarch & Development Ltd. On the basis of the agreeme... Read more

Tags collaboration , Synektik , radiopharmaceuticals , PET , cardiac diseases , Cezary Dariusz Kozanecki